United Kingdom · 
Who invested in Vicebio?
Vicebio's investors include TCG Crossover, Goldman Sachs, TCG, venBio Partners and Goldman Sachs Alternatives, and 3 more on record. TCG Crossover led its latest round.
United Kingdom · Series B startup
Who invested in Vicebio
Funding summaryUpdated 26 Oct 2026
$100Mraised across 1 round since 2024, from 2 sources
- Latest round
- Series B, $100MSept 2024
- Led by
- TCG Crossover
- Investors
- 8 (1 led)
The rounds
- Sept 2024Series B$100M
TCG CrossoverLead
Goldman Sachs
TCG
venBio Partners- Goldman Sachs Alternatives
Medicxi
Avoro Ventures
UniQuest
Reported by Firms' own news pages and 1 other
Everyone who backed them
Goldman Sachs AlternativesGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Vicebio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Vicebio
How much has Vicebio raised?
Vicebio has raised $100M across 1 round since 2024.
When did Vicebio last raise?
Vicebio's most recent round was a Series B of $100M in Sept 2024, led by TCG Crossover.
What was Vicebio's biggest round?
Its most recent round, $100M in Sept 2024, is also its largest on record.
Who backed Vicebio first?
Vicebio's first round on record, in Sept 2024, was backed by TCG Crossover, Goldman Sachs and TCG and 5 others.
What stage is Vicebio at?
Vicebio's latest named round is a Series B, in Sept 2024.
Where is Vicebio based?
Vicebio is based in the United Kingdom.
Who led Vicebio's rounds?
TCG Crossover led the Series B in 2024.
Companies like Vicebio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.